Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 863,197 | 828,601 | 602,562 | 427,811 | 392,507 |
| Marketable Securities | 709,869 | 431,610 | 620,167 | 240,882 | 275,163 |
| Receivables | 1,002,328 | 1,018,487 | 824,406 | 891,396 | 861,457 |
| Inventories | 715,935 | 672,750 | 659,003 | 614,483 | 570,390 |
| Other current assets | 633,684 | 573,576 | 478,796 | 469,100 | 423,704 |
| TOTAL | $3,925,013 | $3,525,024 | $3,184,934 | $2,643,672 | $2,523,221 |
| Non-Current Assets | |||||
| PPE Net | 1,756,164 | 1,744,266 | 1,750,710 | 1,806,074 | 1,787,776 |
| Investments And Advances | 1,622,628 | 1,363,541 | 1,220,122 | 1,009,586 | 640,991 |
| Intangibles | 5,614,193 | 5,597,300 | 5,707,569 | 5,790,917 | 5,889,602 |
| Other Non-Current Assets | -1 | 0 | -1 | 0 | 0 |
| TOTAL | $8,992,984 | $8,705,107 | $8,678,400 | $8,606,577 | $8,318,369 |
| Total Assets | $12,918,000 | $12,230,130 | $11,863,330 | $11,250,250 | $10,841,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 224,931 | 212,809 | 219,913 | 166,709 | 163,094 |
| Accrued Expenses | 1,495,549 | 1,216,843 | 1,355,187 | 1,204,437 | 1,056,229 |
| TOTAL | $1,916,624 | $1,594,247 | $1,758,279 | $1,518,711 | $1,304,074 |
| Non-Current Liabilities | |||||
| Long Term Debt | 586,091 | 591,012 | 592,433 | 694,894 | 726,388 |
| Other Non-Current Liabilities | 702,339 | 703,136 | 659,231 | 608,473 | 595,642 |
| TOTAL | $1,436,148 | $1,494,821 | $1,484,218 | $1,605,850 | $1,635,371 |
| Total Liabilities | $3,352,772 | $3,089,068 | $3,242,497 | $3,124,561 | $2,939,445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 236,145 | 237,200 | 236,000 | 236,213 | 237,672 |
| Common Shares | 128 | 128 | 128 | 128 | 128 |
| Retained earnings | 7,543,597 | 6,829,091 | 6,349,135 | -29,315 | 5,404,213 |
| Other shareholders' equity | -22,583 | -17,930 | -27,076 | 5,892,498 | -54,181 |
| TOTAL | $9,565,226 | $9,141,063 | $8,620,838 | $8,125,688 | $7,902,145 |
| Total Liabilities And Equity | $12,917,998 | $12,230,131 | $11,863,335 | $11,250,249 | $10,841,590 |